Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'I TRIAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 1414 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. McGinn, CJ; Zalupski, MM
      Combined-modality therapy in pancreatic cancer: Current status and future directions

      CANCER JOURNAL
    2. van de Wijgert, J; Fullem, A; Kelly, C; Mehendale, S; Rugpao, S; Kumwenda, N; Chirenje, Z; Joshi, S; Taha, T; Padian, N; Bollinger, R; Nelson, K
      Phase 1 trial of the topical microbicide BufferGel: Safety results from four international sites

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Rahman, A; Tsai, V; Goudreau, A; Shinoda, JY; Wen, SF; Ramachandra, M; Ralston, R; Maneval, D; LaFace, D; Shabram, P
      Specific depletion of human anti-adenovirus antibodies facilitates transduction in an in vivo model for systemic gene therapy

      MOLECULAR THERAPY
    4. Djeha, AH; Thomson, TA; Leung, H; Searle, PF; Young, LS; Kerr, DJ; Harris, PA; Mountain, A; Wrighton, CJ
      Combined adenovirus-mediated nitroreductase gene delivery and CB1954 treatment: A well-tolerated therapy for established solid tumors

      MOLECULAR THERAPY
    5. Sawai, N; Zhou, S; Vanin, EF; Houghton, P; Brent, TP; Sorrentino, BP
      Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector

      MOLECULAR THERAPY
    6. June, CH
      Can't get any help? New approaches for adoptive immunotherapy of cancer

      JOURNAL OF IMMUNOTHERAPY
    7. Bodell, WJ; Giannini, DD; Hassenbusch, S; Levin, VA
      Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors

      NEURO-ONCOLOGY
    8. Gunzburg, WH; Salmons, B
      Novel clinical strategies for the treatment of pancreatic carcinoma

      TRENDS IN MOLECULAR MEDICINE
    9. Brinkmann, U; Keppler-Hafkemeyer, A; Hafkemeyer, P
      Recombinant immunotoxins for cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    10. Alavi, JB; Eck, SL
      Gene therapy for high grade gliomas

      EXPERT OPINION ON BIOLOGICAL THERAPY
    11. Davies, CH
      Revascularization for cardiogenic shock

      QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    12. O'Hagan, DT; MacKichan, ML; Singh, M
      Recent developments in adjuvants for vaccines against infectious diseases

      BIOMOLECULAR ENGINEERING
    13. Ciccolini, J; Catalin, J; Blachon, MF; Durand, A
      Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction

      JOURNAL OF CHROMATOGRAPHY B
    14. Frenkel, GD; Caffrey, PB
      A prevention strategy for circumventing drug resistance in cancer chemotherapy

      CURRENT PHARMACEUTICAL DESIGN
    15. Johnson, PWM
      The therapeutic use of antibodies for malignancy

      TRANSFUSION CLINIQUE ET BIOLOGIQUE
    16. Frankel, AE; Schuster, MW; Jurcic, JG
      Novel therapeutics for chemotherapy-resistant acute myeloid leukaemia

      BIODRUGS
    17. Angeja, BG; Gibson, CM; Chin, R; Canto, JG; Barron, HV
      Use of reperfusion therapies in elderly patients with acute myocardial infarction

      DRUGS & AGING
    18. Coze, C; Leimig, T; Jimeno, MT; Mannoni, P
      Retrovirus-mediated gene transfer of the cytokine genes interleukin-1 betaand tumor necrosis factor-alpha into human neuroblastoma cells: consequences for cell line behavior and immunomodulatory properties

      EUROPEAN CYTOKINE NETWORK
    19. Dalakas, MC
      Peripheral neuropathy and antiretroviral drugs

      JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
    20. Buchsbaum, DJ; Curiel, DT
      Gene therapy for the treatment of cancer

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    21. Crombet, T; Torres, O; Neninger, E; Catala, M; Rodriguez, N; Ramos, M; Fernandez, E; Iznaga, N; Perez, R; Lage, A
      Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    22. Margolin, K; Synold, T; Longmate, J; Doroshow, JH
      Methodologic guidelines for the design of high-dose chemotherapy regimens

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    23. Khan, SA; Gaa, B; Pollock, BH; Shea, B; Reddy, V; Wingard, YR; Moreb, JS
      Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    24. Friedberg, JW; Neuberg, D; Monson, J; Jallow, H; Nadler, LM; Freedman, AS
      The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    25. Somlo, G; Chow, W; Hamasaki, V; Leong, L; Margolin, K; Morgan, R; Sniecinski, I; Frankel, P; Reardon, D; Longmate, J; Raschko, J; Shibata, S; O'Donnell, M; Smith, E; Tetef, M; Forman, S; Yen, Y; Molina, A; Doroshow, JH
      Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    26. Kirn, D; Martuza, RL; Zwiebel, J
      Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

      NATURE MEDICINE
    27. Wieder, J; Freedland, SJ; Pantuck, AJ; Zisman, A; Belldegrun, AS
      Update on gene and immune based therapy for urologic malignancy

      UROLOGIC ONCOLOGY
    28. Xu, G; McLeod, HL
      Strategies for enzyme/prodrug cancer therapy

      CLINICAL CANCER RESEARCH
    29. Anderson, CP; Seeger, RC; Satake, N; Monforte-Munoz, HL; Keshelava, N; Bailey, HH; Reynolds, CP
      Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell line

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    30. Dillman, RO
      Monoclonal antibody therapy for lymphoma - An update

      CANCER PRACTICE
    31. Sereti, I; Lane, HC
      Immunopathogenesis of human immunodeficiency virus: Implications for immune-based therapies

      CLINICAL INFECTIOUS DISEASES
    32. McGinn, CJ; Lawrence, TS
      Recent advances in the use of radio sensitizing nucleosides

      SEMINARS IN RADIATION ONCOLOGY
    33. Berry, SE; Kinsella, TJ
      Targeting DNA mismatch repair for radiosensitization

      SEMINARS IN RADIATION ONCOLOGY
    34. Chmura, SJ; Gupta, N; Advani, SJ; Kufe, DW; Weichselbaum, RR
      Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation

      SEMINARS IN RADIATION ONCOLOGY
    35. Imperiale, MJ; Pass, HI; Sanda, MG
      Prospects for an SV40 vaccine

      SEMINARS IN CANCER BIOLOGY
    36. Kianmanesh, A; Hackett, NR; Lee, JM; Kikuchi, T; Korst, RJ; Crystal, RG
      Intratumoral administration of low doses of an adenovirus vector encoding tumor necrosis factor alpha together with naive dendritic cells elicits significant suppression of tumor growth without toxicity

      HUMAN GENE THERAPY
    37. Flaherty, KT; Stevenson, JP; O'Dwyer, PJ
      Antisense therapeutics: lessons from early clinical trials

      CURRENT OPINION IN ONCOLOGY
    38. Reff, ME; Heard, C
      A review of modifications to recombinant antibodies: attempt to increase efficacy in oncology applications

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    39. Goldenberg, DM
      The role of radiolabeled antibodies in the treatment of non-Hodgkin's lymphoma: the coming of age of radioimmunotherapy

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    40. DeNardo, GL; Juweid, ME; White, CA; Wiseman, GA; DeNardo, SJ
      Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    41. Calderoni, A; Cerny, T
      Taxanes in lung cancer: a review with focus on the European experience

      CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
    42. Shimizu, Y; Utsugi, K; Umezawa, S; Shimizu, K; Hasumi, K; Suzuki, M; Takaku, F
      Effect of human urinary macrophage colony-stimulating factor on the immunefunctions and the blood cell counts in patients with ovarian carcinoma receiving cytotoxic chemotherapy

      ONCOLOGY REPORTS
    43. Farmer, JP; Montes, JL; Freeman, CR; Meagher-Villemure, K; Bond, MC; O'Gorman, AM
      Brainstem gliomas - A 10-year institutional review

      PEDIATRIC NEUROSURGERY
    44. Eaton, JD; Perry, MJA; Todryk, SM; Mazucco, RA; Kirby, RS; Griffiths, JR; Dalgleish, AG
      Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques

      GENE THERAPY
    45. Mulvihlll, S; Warren, R; Venook, A; Adler, A; Randlev, B; Heise, C; Kirn, D
      Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

      GENE THERAPY
    46. Hashiba, T; Suzuki, M; Nagashima, Y; Suzuki, S; Inoue, S; Tsubarai, T; Matsuses, T; Ishigatubo, Y
      Adenovirus-mediated transfer of heme oxygenase-1 cDNA attenuates severe lung injury induced by the influenza virus in mice

      GENE THERAPY
    47. Lambright, ES; Amin, K; Wiewrodt, R; Force, SD; Lanuti, M; Propert, KJ; Litzky, L; Kaiser, LR; Albelda, SM
      Inclusion of the herpes simplex thymidine kinase gene in a replicating adenovirus does not augment antitumor efficacy

      GENE THERAPY
    48. Antczak, C; Bauvois, B; Monneret, C; Florent, JC
      A new acivicin prodrug designed for tumor-targeted delivery

      BIOORGANIC & MEDICINAL CHEMISTRY
    49. Antman, KH
      A critique of the eleven randomised trials of high-dose chemotherapy for breast cancer

      EUROPEAN JOURNAL OF CANCER
    50. Brandes, AA; Lacombe, D; Vecht, C
      Future trends in the treatment of brain tumours

      EUROPEAN JOURNAL OF CANCER
    51. Hoff, PM; Saad, ED; Ravandi-Kashani, F; Czerny, E; Pazdur, R
      Phase I trial of i.v. administered tirapazamine plus cyclophosphamide

      ANTI-CANCER DRUGS
    52. Sonneveld, P
      Multidrug resistance in haematological malignancies (Reprinted from Journal of Internal Medicine, vol 247, pg 521-534, 2000)

      JOURNAL OF INTERNAL MEDICINE
    53. Baumhakel, M; Kasel, D; Rao-Schymanski, RA; Bocker, R; Beckurts, KT; Zaigler, M; Barthold, D; Fuhr, U
      Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    54. Maleniak, TC; Darling, JL; Lowenstein, PR; Castro, MG
      Adenovirus-mediated expression of HSV1-TK or Fas ligand induces cell deathin primary human glioma-derived cell cultures that are resistant to the chemotherapeutic agent CCNU

      CANCER GENE THERAPY
    55. Bollard, CM; Heslop, HE; Brenner, MK
      Gene-marking studies of hematopoietic cells

      INTERNATIONAL JOURNAL OF HEMATOLOGY
    56. Kern, W; Beckert, B; Lang, N; Stemmler, J; Beykirch, M; Stein, J; Goecke, E; Waggershauser, T; Braess, J; Schalhorn, A; Hiddemann, W
      Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer

      ANNALS OF ONCOLOGY
    57. Kornblith, AB; Herndon, JE; Zuckerman, E; Godley, PA; Savarese, D; Vogelzang, NJ; Holland, JC
      The impact of docetaxel, estramustine, and low dose hydrocortisone on the quality of life of men with hormone refractory prostate cancer and their partners: A feasibility study

      ANNALS OF ONCOLOGY
    58. Tate, J; Olencki, T; Finke, J; Kottke-Marchant, K; Rybicki, LA; Bukowski, RM
      Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: Clinical and laboratory effects

      ANNALS OF ONCOLOGY
    59. Pfreundschuh, M; Hasenclever, D; Loeffler, M; Ehninger, G; Schmitz, N; Kirchner, H; Koch, P; Lathan, B; Rueffer, U; Sextro, M; Franklin, J; Tesch, H; Diehl, V
      Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF

      ANNALS OF ONCOLOGY
    60. Hidalgo, M; Eckhardt, SG
      Matrix metalloproteinase inhibitors: How can we optimize their development?

      ANNALS OF ONCOLOGY
    61. Rothenberg, ML; Kuhn, JG; Schaaf, LJ; Rodriguez, GI; Eckhardt, SG; Villalona-Calero, MA; Rinaldi, DA; Hammond, LA; Hodges, S; Sharma, A; Elfring, GL; Petit, RG; Locker, PK; Miller, LL; von Hoff, DD
      Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

      ANNALS OF ONCOLOGY
    62. Natale, RB
      Gemcitabine and nonplatinum combinations in non-small-cell Lung cancer

      ONCOLOGY-NEW YORK
    63. Vose, JM
      Immunotherapy for non-Hodgkin's lymphoma

      ONCOLOGY-NEW YORK
    64. Wasserman, TH; Brizel, DM
      The role of amifostine as a radioprotector

      ONCOLOGY-NEW YORK
    65. Bernstein, ML; Reaman, GH; Hirschfeld, S
      Developmental therapeutics in childhood cancer - A perspective from the Children's Oncology Group and the US Food and Drug Administration

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    66. Perentesis, JP; Sievers, EL
      Targeted therapies for high-risk acute myeloid leukemia

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    67. Rousseau, RF; Hirschmann-Jax, C; Takahashi, S; Brenner, MK
      Cancer vaccines

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    68. Hollenberg, SM
      Cardiogenic shock

      CRITICAL CARE CLINICS
    69. Pilati, P; Rossi, CR; Mocellin, S; Foletto, M; Scagnet, B; Pasetto, L; Lise, M
      Multimodal treatment of peritoneal carcinomatosis and sarcomatosis

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    70. Flanagan, DL; Gross, R; Jennings, CD; Caywood, BE; Goes, S; Kaplan, AM; Bryson, JS
      Induction of syngeneic graft-versus-host disease in LPS hyporesponsive C3H/HeJ mice

      JOURNAL OF LEUKOCYTE BIOLOGY
    71. de Lemos, JA; Braunwald, E
      ST segment resolution as a tool for assessing the efficacy of reperfusion therapy

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    72. Bahit, MC; Topol, EJ; Califf, RM; Armstrong, PW; Criger, DA; Hasselblad, V; Betriu, A; Hirsh, J; Ardissino, D; Granger, CB
      Reactivation of ischemic events in acute coronary syndromes: Results from GUSTO-IIb

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    73. Roe, MT; Ohman, EM; Maas, ACP; Christenson, RH; Mahaffey, KW; Granger, CB; Harrington, RA; Califf, RM; Krucoff, MW
      Shifting the open-artery hypothesis downstream: The quest for optimal reperfusion

      JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
    74. Mhashilkar, A; Chada, S; Roth, JA; Ramesh, R
      Gene therapy - Therapeutic approaches and implications

      BIOTECHNOLOGY ADVANCES
    75. Apisarnthanarax, N; Duvic, M
      Cutaneous T-cell lymphoma - New immunomodulators

      DERMATOLOGIC CLINICS
    76. Prieto, A; Eisenberg, J; Thakur, RK
      Nonarrhythmic complications of acute myocardial infarction

      EMERGENCY MEDICINE CLINICS OF NORTH AMERICA
    77. Curtin, JP; Blessing, JA; Webster, KD; Rose, PG; Mayer, AR; Fowler, WC; Malfetano, JH; Alvarez, RD
      Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: A Gynecologic Oncology Group Study

      JOURNAL OF CLINICAL ONCOLOGY
    78. Sunwoo, JB; Herscher, LL; Kroog, GS; Thomas, GR; Ondrey, FG; Duffey, DC; Solomon, BI; Boss, C; Albert, PS; McCullugh, L; Rudy, S; Muir, C; Zhai, S; Figg, WD; Cook, JA; Mitchell, JB; Van Waes, C
      Concurrent paclitaxel and radiation in the treatment of locally advanced head and neck cancer

      JOURNAL OF CLINICAL ONCOLOGY
    79. Kurzrock, R; Cortes, J; Thomas, DA; Jeha, S; Pilat, S; Talpaz, M
      Pilot study of low-dose interleukin-11 in patients with bone marrow failure

      JOURNAL OF CLINICAL ONCOLOGY
    80. Cheson, BD
      Some like it hot!

      JOURNAL OF CLINICAL ONCOLOGY
    81. Lee, P; Wang, F; Kuniyoshi, J; Rubio, V; Stuges, T; Groshen, S; Gee, C; Lau, R; Jeffery, G; Margolin, K; Marty, V; Weber, J
      Effects of interleukin-12 on the immune response to a multipeptide vaccinefor resected metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    82. Regine, WF; Valentino, J; Arnold, SM; Haydon, RC; Sloan, D; Kenady, D; Strottmann, J; Pulmano, C; Mohiuddin, M
      High-dose intra-arterial cisplatin boost with hyperfractionated radiation therapy for advanced squamous cell carcinoma of the head and neck

      JOURNAL OF CLINICAL ONCOLOGY
    83. Kelly, K; Crowley, J; Bunn, PA; Presant, CA; Grevstad, PK; Mainpour, CM; Ramsey, SD; Wozniak, AJ; Weiss, GR; Moore, DF; Israel, VK; Livingston, RB; Gandara, DR
      Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-celllung cancer: A Southwest Oncology Group trial

      JOURNAL OF CLINICAL ONCOLOGY
    84. Kelly, WK; Curley, T; Slovin, S; Heller, G; McCaffrey, J; Bajorin, D; Ciolino, A; Regan, K; Schwartz, M; Kantoff, P; George, D; Oh, W; Smith, M; Kaufman, D; Small, EJ; Schwartz, L; Larson, S; Tong, W; Scher, H
      Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer

      JOURNAL OF CLINICAL ONCOLOGY
    85. Korn, EL; Arbuck, SG; Pluda, JM; Simon, R; Kaplan, RS; Christian, MC
      Clinical trial designs for cytostatic agents: Are new approaches needed?

      JOURNAL OF CLINICAL ONCOLOGY
    86. Kollmannsberger, C; Mayer, F; Kuczyk, M; Kanz, L; Bokemeyer, C
      Treatment of patients with metastatic germ cell tumors relapsing after high-dose chemotherapy

      WORLD JOURNAL OF UROLOGY
    87. Saha, S; Mondal, S
      Suppression of Ehrlich subcutaneous solid tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype antibody

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    88. Akiyama, Y; Ohe, Y; Tamura, T; Sawada, M; Inoue, A; Kusaba, H; Yamamoto, N; Sekine, I; Kunitoh, H; Kodama, T; Saijo, N
      A dose escalation study of paclitaxel and carboplatin in untreated Japanese patients with advanced non-small cell lung cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    89. Okada, S; Ueno, H; Okusaka, T; Ikeda, M; Furuse, J; Maru, Y
      Phase I trial of gemcitabine in patients with advanced pancreatic cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    90. Vandenbark, AA; Morgan, E; Bartholomew, R; Bourdette, D; Whitham, R; Carlo, D; Gold, D; Hashim, G; Offner, H
      TCR peptide therapy in human autoimmune diseases

      NEUROCHEMICAL RESEARCH
    91. Xu, S; Zakian, K; Thaler, H; Matei, C; Alfleri, A; Chen, YC; Koutcher, JA
      Effects of motexafin gadolinium on tumor metabolism and radiation sensitivity

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    92. Kornek, GV; Potter, R; Selzer, E; Schratter, A; Ulrich-Pur, H; Rogy, M; Kraus, G; Scheithauer, W
      Combined radiochemotherapy of locally advanced unresectable pancreatic adenocarcinoma with mitomycin C plus 24-hour continuous infusional gemcitabine

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    93. Mehta, M; Scrimger, R; Mackie, R; Paliwal, B; Chappell, R; Fowler, J
      A new approach to dose escalation in non-small-cell lung cancer

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    94. Koch, CJ; Hahn, SM; Rockwell, K; Covey, JM; McKenna, WG; Evans, SM
      Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitrolmidazoles

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    95. Edelman, MJ; Quam, H; Mullins, B
      Interactions of gemcitabine, carboplatin and paclitaxel in molecularly defined non-small-cell lung cancer cell lines

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    96. Witzig, TE
      Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    97. Fyfe, D; Price, C; Langley, RE; Pagonis, C; Houghton, J; Osborne, L; Woll, PJ; Gardner, C; Baguley, BC; Carmichael, J
      A phase I trial of amsalog (Cl-921) administered by intravenous infusion using a 5-day schedule

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    98. Papadopoulos, KP; Egorin, MJ; Huang, M; Troxel, AB; Kaufman, E; Balmaceda, CM; Vahdat, LT; Hesdorffer, CS
      The pharmacokinetics and pharmacodynamics of high-dose paclitaxel monotherapy (825 mg/m(2) continuous infusion over 24 h) with hematopoietic support in women with metastatic breast cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    99. Nakamura, K; Tanaka, Y; Shitara, K; Hanai, N
      Construction of humanized anti-ganglioside monoclonal antibodies with potent immune effector functions

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    100. Hamada, S; Nakamura, S; Sugiura, T; Nishiue, T; Watanabe, J; Hatada, K; Miyoshi, H; Baden, M; Iwasaka, T
      Accuracy of technetium-99m tetrofosmin myocardial perfusion imaging in thedetection of spontaneous recanalization in patients with acute anterior myocardial infarction

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/05/20 alle ore 20:41:08